439 related articles for article (PubMed ID: 17868147)
1. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress.
Carrasco E; Werner P; Casper D
Neurosci Lett; 2008 Aug; 441(1):44-9. PubMed ID: 18597941
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
4. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes.
Del Toro F; Sylvia VL; Schubkegel SR; Campos R; Dean DD; Boyan BD; Schwartz Z
J Cell Physiol; 2000 Feb; 182(2):196-208. PubMed ID: 10623883
[TBL] [Abstract][Full Text] [Related]
5. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
6. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
7. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Echeverria V; Clerman A; Doré S
Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes.
Kanda N; Mitsui H; Watanabe S
J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845
[TBL] [Abstract][Full Text] [Related]
10. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
11. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
14. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
15. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
Jadhav V; Jabre A; Lin SZ; Lee TJ
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
[TBL] [Abstract][Full Text] [Related]
19. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
[TBL] [Abstract][Full Text] [Related]
20. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]